Explore
Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Read More
Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Expansion Plans
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Expansion Plans
Read More
Trendline
ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates
ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates
Read More
Trendline
IDEAYA Biosciences Reports Positive Results and Business Updates for Q1 2026
IDEAYA Biosciences Reports Positive Results and Business Updates for Q1 2026
Read More
Trendline
Summit Shares Plummet as PD-1/VEGF Drug Fails Early Survival Benchmark
Summit Shares Plummet as PD-1/VEGF Drug Fails Early Survival Benchmark
Read More
Trendline
Erasca Shares Plummet Amid Patient Death and Patent Dispute
Erasca Shares Plummet Amid Patient Death and Patent Dispute
Read More
Trendline
IDEAYA Biosciences Reports Positive Trial Results and Financial Update for Q1 2026
IDEAYA Biosciences Reports Positive Trial Results and Financial Update for Q1 2026
Read More
Trendline
Summit Shares Plummet as Cancer Drug Fails Early Survival Benchmark
Summit Shares Plummet as Cancer Drug Fails Early Survival Benchmark
Read More
Trendline
Agenus to Release Q1 2026 Financial Results and Corporate Update
Agenus to Release Q1 2026 Financial Results and Corporate Update
Read More
Trendline
Sarepta, Amylyx, and Neumora Anticipate Key Developments Amidst Q1 Earnings
Sarepta, Amylyx, and Neumora Anticipate Key Developments Amidst Q1 Earnings
Read More
Trendline
Vertex Pharmaceuticals Reports Strong Q1 2026 Financial Results with 8% Revenue Growth
Vertex Pharmaceuticals Reports Strong Q1 2026 Financial Results with 8% Revenue Growth
Read More
Trendline
Pulmonx Corp Reports Decline in Q1 2026 Revenue Amid China Shipment Delays
Pulmonx Corp Reports Decline in Q1 2026 Revenue Amid China Shipment Delays
Read More
